- Home
- ORMP vs AVX Comparison
ORMP vs AVX Comparison
Compare ORMP & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | AVX |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 119.2M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | AVX |
|---|---|---|
| Price | $3.32 | $0.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 164.3K | ★ 821.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 7.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $1,340,000.00 | N/A |
| Revenue This Year | N/A | $530,767.50 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.82 | $0.55 |
| 52 Week High | $3.76 | $2.27 |
Technical Indicators
Market Signals| Indicator | ORMP | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 48.48 | 45.29 |
| Support Level | $3.22 | $0.55 |
| Resistance Level | $3.76 | $2.26 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 28.57 | 78.78 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.